CBC

CBC
Name	Complete blood count
Acronyms	CBC
Purpose	Evaluation of hematologic status, screening for anemia, infection, hematologic malignancy
Sample	Peripheral venous blood
Specimen	EDTA anticoagulated whole blood
Components	Hemoglobin; hematocrit; red blood cell count; mean corpuscular volume; mean corpuscular hemoglobin; mean corpuscular hemoglobin concentration; red cell distribution width; platelet count; white blood cell count and differential

CBC

A complete blood count is a routine hematologic laboratory panel used to quantify cellular elements in peripheral blood and to screen for disorders such as anemia, infection, thrombocytopenia, and hematologic malignancy. It integrates automated analyzers and manual review to report hemoglobin, hematocrit, erythrocyte indices, leukocyte count with differential, and platelet count, providing data used by clinicians in acute care, primary care, oncology, and transfusion medicine. Results guide diagnostic testing, monitoring of therapy, and public health surveillance in conjunction with clinical context and other laboratory investigations.

Overview

A complete blood count reports quantitative and derived measures: hemoglobin concentration, hematocrit (packed cell volume), red blood cell (erythrocyte) count, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red cell distribution width (RDW), total white blood cell (leukocyte) count, automated or manual leukocyte differential (neutrophils, lymphocytes, monocytes, eosinophils, basophils), and platelet count. Modern hematology analyzers from manufacturers such as Sysmex, Beckman Coulter, Siemens Healthineers, and Abbott Laboratories combine impedance, optical scatter, and fluorescent flow cytometry to enumerate and classify cells. Clinicians in settings including intensive care units, primary care clinics, hematology services, and oncology clinics rely on CBC trends for therapeutic decisions.

History

Automated counting evolved from manual microscopy pioneered in the late 19th and early 20th centuries by investigators like Karl Landsteiner and Paul Ehrlich, with early hemoglobinometry by Otto Folin and packed cell determinations influenced by the work of William Henry Welch. The Coulter principle, patented in 1956 by Joseph R. Coulter, enabled rapid electrical impedance counting and transformed laboratory hematology. Later innovations—flow cytometry advances by Leonard Herzenberg and optical scatter and fluorescent reagents developed by commercial firms such as Coulter Corporation and Becton Dickinson—expanded differential capabilities and reticulocyte analysis. Regulatory landmarks including standards from Clinical Laboratory Improvement Amendments and accreditation by organizations like College of American Pathologists shaped quality and reporting.

Procedure and Methodology

Specimen collection uses venipuncture into EDTA tubes, avoiding hemolysis and clot formation; anticoagulant concentration and collection technique affect cell morphology and counts. Automated analyzers perform erythrocyte and platelet counts via impedance or optical methods, hemoglobin by cyanmethemoglobin or photometric methods, and leukocyte differentiation using light scatter and fluorescent staining. Manual smear review with Wright-Giemsa staining on glass slides by laboratory technologists or pathologists identifies morphologic abnormalities such as schistocytes, spherocytes, hypersegmented neutrophils, blasts, and platelet clumping. Quality control employs internal controls and external proficiency testing from providers like College of American Pathologists and national reference laboratories associated with Centers for Disease Control and Prevention programs.

Reference Ranges and Interpretation

Reference intervals vary by age, sex, altitude, pregnancy status, and laboratory methods; typical adult ranges include hemoglobin ~13.5–17.5 g/dL in males and ~12.0–15.5 g/dL in females, hematocrit ~41–53% (males) and ~36–46% (females), platelet count 150–450 ×10^9/L, and WBC 4.0–11.0 ×10^9/L. Pediatric norms differ substantially, with newborns having higher hemoglobin and hematocrit. Interpretation integrates clinical entities such as iron deficiency, vitamin B12 deficiency, hemolysis, hemorrhage, chronic kidney disease, bone marrow failure, aplastic anemia, myelodysplastic syndromes, and acute leukemia described in texts by organizations like World Health Organization and guidelines from specialty societies including American Society of Hematology.

Clinical Applications

CBC is used for screening and monitoring in contexts such as preoperative assessment in surgery services, surveillance during chemotherapy for breast cancer or leukemia treatment, diagnosis of infections (neutrophilia, left shift) including sepsis, evaluation of bleeding disorders and thrombocytopenia in immune thrombocytopenia purpura or thrombotic microangiopathies like thrombotic thrombocytopenic purpura, and population screening for anemia in public health programs coordinated with entities such as World Health Organization and national ministries of health. In transfusion medicine, CBC guides red cell and platelet transfusion thresholds recommended by groups like AABB and in obstetrics for prenatal anemia management referenced by Royal College of Obstetricians and Gynaecologists.

Limitations and Sources of Error

Preanalytical variables—tourniquet time, fist clenching, delayed processing, improper tube filling, and specimen transport conditions—alter results. Analytical limitations include analyzer-specific biases, interference from cold agglutinins, lipemia, hemolysis, or high leukocyte counts causing pseudohyperkalemia or spurious results. Platelet clumping due to inadequate anticoagulation or EDTA-induced pseudothrombocytopenia necessitates repeat sampling with alternate anticoagulants (citrate, heparin) and manual smear confirmation. Interpretation pitfalls include physiologic variation with altitude and pregnancy and confounding from chronic inflammatory states or recent transfusion; guidelines from Clinical and Laboratory Standards Institute address validation and reporting.

Epidemiology and Public Health Impact

CBC-derived metrics contribute to epidemiologic surveillance of anemia prevalence, infectious disease burden, and hematologic malignancy incidence in population studies by agencies such as World Health Organization, Centers for Disease Control and Prevention, and national health surveys like the National Health and Nutrition Examination Survey. Trends in anemia inform nutrition and micronutrient programs, while leukocyte and platelet abnormalities detected in screening can trigger case-finding for outbreaks or occupational exposures documented by Occupational Safety and Health Administration and public health authorities. Laboratory capacity building initiatives by organizations including Global Health Security Agenda and World Bank investments aim to expand access to reliable CBC testing in low-resource settings.

Category:Blood tests